Average Co-Inventor Count = 7.76
ph-index = 18
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bayer Aktiengesellschaft (14 from 12,167 patents)
2. Bayer Healthcare LLC (9 from 780 patents)
3. Bayer Pharmaceuticals Corporation (4 from 71 patents)
4. Bayer Intellectual Property Gmbh (1 from 721 patents)
5. Bayer Pharma Aktiengesellschaft (1 from 378 patents)
6. Aicuris Gmbh + Co. Kg. (1 from 53 patents)
7. Bayer Schering Pharma Ag (192 patents)
8. Aicuris Anti-Infective Cures Gmbh (9 patents)
9. Aicuris Gmbh & Co. Kg (0 patent)
30 patents:
1. 9493472 - Substituted benzoxazoles
2. 9181188 - Aryl ureas as kinase inhibitors
3. 8841330 - Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
4. 8637553 - Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
5. 8318761 - Substituted arylsulfonamides as antiviral agents
6. 8304406 - Compounds for treating pulmonary hypertension
7. 8124630 - ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
8. 8110587 - Aryl ureas as kinase inhibitors
9. 8071616 - Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors
10. 7928239 - Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
11. 7897623 - ω-carboxyl aryl substituted diphenyl ureas as p38 kinase inhibitors
12. 7678811 - Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors
13. 7528255 - Hydroxy, ω-carboxyaryl substituted diphenyl ureas and dirivatives thereof as raf kinase inhibitors
14. 7371763 - Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
15. 7351834 - ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors